A Phase I Extension Trial of Repeated Infusions of ISF35
NCT00783588
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
4
Enrollment
INDUSTRY
Sponsor class
Conditions
Chronic Lymphocytic Leukemia
Interventions
BIOLOGICAL:
ISF35
Sponsor
Memgen, LLC